Home/Filings/4/0001486189-21-000003
4//SEC Filing

Schimmel Lawrence 4

Accession 0001486189-21-000003

CIK 0001479681other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 2:49 PM ET

Size

6.1 KB

Accession

0001486189-21-000003

Insider Transaction Report

Form 4
Period: 2021-01-28
Schimmel Lawrence
DirectorChief Medical Officer
Transactions
  • Award

    Common Stock

    2021-01-28$0.65/sh+107,692$70,000234,047 total
Holdings
  • Officer Stock Option (right to buy)

    Exercise: $1.50From: 2020-01-20Exp: 2027-01-20Common Stock (36,288 underlying)
    36,288
Footnotes (1)
  • [F1]30,000 options Quarterly 25% starting April 1, 2020,fully vested upon change in control, fully vested upon closing of merger. 6,288 vest on 1/27/2020

Issuer

Clinigence Holdings, Inc.

CIK 0001479681

Entity typeother

Related Parties

1
  • filerCIK 0001793716

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 2:49 PM ET
Size
6.1 KB